Clinical Trial
Published on 30 Oct 2023
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study
in Cancer Immunity and Immunotherapy
- 5,941 views
- 6 citations













